维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="BALTHASAR S"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumor cells显示文摘	Wartlick H Michaelis K Balthasar S	2004	J Drug Target2004，12，7：	1
2	Characterization of serum albumin nanoparticles by sedimentation velocity analysis and electron microscopy显示文摘	Vogel V Langer K Balthasar S etal	2002	Prog Colloid Polym Sci2002，119，：	1
3	Optimization of the preparation process for human serum albumin (HSA) nanoparticles 显示文摘	Langer K Balthasar S Vogel V	2003	Int J Pharm2003，257，12：	1
4	Inhibitory effects of verapamil isomers on the proliferation of choroidal endothelial cells显示文摘	Hoffmann S Balthasar S Friedrichs U Ehren M Ryan SJ Wiedemann P	2006	Graefe Arch Clin Exp Ophthalmol2006，244，3：	1
5	Optimization of thepreparation process for human serum albumin(HSA) nanoparticles显示文摘	K Langer S Balthasar V Vogel	2003	International Journal of Pharmaceutics2003，257，12：	1
6	Optimization of thepreparation process for human serum albumin (HSA)nanoparticles 显示文摘	Langer K Balthasar S Vogel V	2003	Int J Pharm2003，257，12：	1
7	Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes 显示文摘	Balthasar S Miehaelis K Dinauer N	2005	Biomaterials2005，26，15：	1
8	Optimization of the preparation process for human serum albumin(HSA) nanoparticles 显示文摘	LANGER K BALTHASAR S VOGEL V	2003	Int J Pharm2003，257，12：	1
9	Optimization of the preparation process for human serum albumin (HSA) nanoparticles显示文摘	Langer K Balthasar S Vogel V	2003	Int J Pharm2003，257，12：	1
10	Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes显示文摘	Balthasar S Michaelis K Dinauer N		0，，15：	1
11	Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes显示文摘	Balthasar S Michaelis K Dinauer N	2005	Biomaterials2005，26，15：	1
12	Factors af- feeting perceptual thresholds in epiretinal prostheses 显示文摘	DE BALTHASAR C PATEL S ROY A	2008	Invest Ophthalmol Vis Sci2008，49，6：	1
13	Optimization of the preparation process for human serum albumin (HSA) nanopartieles显示文摘	Langer K Balthasar S Vogel V	2003	Int J Pharm2003，257，12：	1
14	Optimization of the preparation process for human serum albumin (HSA) nano- particles显示文摘	Langer K Balthasar S Vogel V	2003	International Journal of Pharmaceutics2003，252，12：	1
15	Optimization of the preparation process for human serum albumin (HSA) nanoparticles显示文摘	Langer K Balthasar S Vogel V	2003	Int J Pharm2003，257，12：	1
16	Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes 显示文摘	Dinauer N Balthasar S Weber C	2005	Biomaterials2005，26，29：	1
17	S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration显示文摘	BERGELIN N LOF C BALTHASAR S	2010	Endocrinoloqv2010，151，7：	1
18	Optimization of the preparation process for human serum albumin (HSA) nanoparticles显示文摘	LANGER K BALTHASAR S VOGEL V	2003	Int J Pharm2003，257，12：	1
19	Scaling up of naphtha cracking coils显示文摘	van Damme P S Froment G F Balthasar W B	1981	I E C Proc Des Dev1981，20，：	1
20	Factors af fecting perceptual thresholds in epiretinal prostheses 显示文摘	de Balthasar C Patel S Roy A	2008	Investigative Ophthalmology & Visual Science2008，49，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示